David A. Siegel Prothena Corp Public LTD CO Transaction History
Two Sigma Advisers, LP
- $42.5 Billion
- Q1 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Two Sigma Advisers, LP holds 8,300 shares of PRTA stock, worth $171,312. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,300
Previous 146,800
94.35%
Holding current value
$171,312
Previous $5.33 Million
96.16%
% of portfolio
0.0%
Previous 0.01%
Shares
25 transactions
Others Institutions Holding PRTA
# of Institutions
186Shares Held
45.4MCall Options Held
119KPut Options Held
144K-
Eco R1 Capital, LLC San Francisco, CA11.6MShares$239 Million8.18% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.2MShares$86.7 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA3.75MShares$77.4 Million0.02% of portfolio
-
Black Rock Inc. New York, NY3.72MShares$76.8 Million0.0% of portfolio
-
State Street Corp Boston, MA3.47MShares$71.7 Million0.0% of portfolio
About PROTHENA CORP PUBLIC LTD CO
- Ticker PRTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,922,800
- Market Cap $968M
- Description
- Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...